Impaired glucose tolerance and dyslipidaemia as late effects after bone-marrow transplantation in childhood.
about
Partial lipodystrophy in patients who have undergone hematopoietic stem cell transplantation during childhood: an institutional cross-sectional survey.Long-term consequences of hematopoietic stem cell transplantation: current state of the science.Hypertension in long-term survivors of pediatric hematopoietic cell transplantation.Predictors of late cardiovascular complications in survivors of hematopoietic cell transplantation.Increased cardiometabolic traits in pediatric survivors of acute lymphoblastic leukemia treated with total body irradiation.Adverse metabolic and cardiovascular risk following treatment of acute lymphoblastic leukaemia in childhood; two case reports and a literature review.Late effects in survivors of acute leukemia treated with hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study.Late altered organ function in very long-term survivors after allogeneic hematopoietic stem cell transplantation: a paired comparison with their HLA-identical sibling donor.Adverse obstetric and perinatal outcomes following treatment of adolescent and young adult cancer: a population-based cohort studyVitamin D deficiency in children with a chronic illness-seasonal and age-related variations in serum 25-hydroxy Vitamin D concentrations.Endocrine late effects after bone marrow transplant.The metabolic syndrome and body composition in childhood cancer survivorsAcquired non-type 1 diabetes in childhood: subtypes, diagnosis, and management.National Cancer Institute-National Heart, Lung and Blood Institute/pediatric Blood and Marrow Transplant Consortium First International Consensus Conference on late effects after pediatric hematopoietic cell transplantation: long-term organ damage aWeekly measurements accurately represent trends in resting energy expenditure in children undergoing hematopoietic stem cell transplantation.Diabetes, hypertension, and cardiovascular events in survivors of hematopoietic cell transplantation: a report from the bone marrow transplantation survivor study.Physical Activity, Fitness, and Cardiometabolic Risk Factors in Adult Survivors of Childhood Cancer with a History of Hematopoietic Cell TransplantationAdverse Fat Depots and Marrow Adiposity Are Associated With Skeletal Deficits and Insulin Resistance in Long-Term Survivors of Pediatric Hematopoietic Stem Cell Transplantation.Attenuation of resting energy expenditure following hematopoietic SCT in childrenSevere insulin resistance and hypertriglyceridemia after childhood total body irradiation.Late effects of total body irradiation and hematopoietic stem cell transplant in children under 3 years of age.Cardiovascular risk factors in hematopoietic cell transplantation survivors: role in development of subsequent cardiovascular disease.Diabetes mellitus in long-term survivors of childhood cancer. Increased risk associated with radiation therapy: a report for the childhood cancer survivor study.The development of non-insulin-dependent diabetes after total body irradiation and bone marrow transplantation in adolescence: a case report and literature review.Prognostic factors in the resumption of oral dietary intake after allogeneic hematopoietic stem cell transplantation (HSCT) in childrenA multi-center, randomized, controlled trial of parenteral nutrition titrated to resting energy expenditure in children undergoing hematopoietic stem cell transplantation ("PNTREE"): rationale and design.Pathogenesis and treatment of HIV lipohypertrophyBurden of morbidity in 10+ year survivors of hematopoietic cell transplantation: report from the bone marrow transplantation survivor studyMetabolic Syndrome after Hematopoietic Cell Transplantation: At the Intersection of Treatment Toxicity and Immune Dysfunction.High prevalence of metabolic syndrome after allogeneic hematopoietic cell transplantation.Endocrine Disorders in Childhood Cancer Survivors Treated with Haemopoietic Stem Cell TransplantationMetabolic Syndrome and Cardiovascular Disease after Hematopoietic Cell Transplantation: Screening and Preventive Practice Recommendations from the CIBMTR and EBMTLate effects in patients with Fanconi anemia following allogeneic hematopoietic stem cell transplantation from alternative donors.Cardiac and cardiovascular consequences after haematopoietic stem cell transplantation.Endocrinological late complications after hematopoietic SCT in children.Hyperlipidemia and statin use after allogeneic hematopoietic stem cell transplantation.Abnormal adipose tissue distribution with unfavorable metabolic profile in five children following hematopoietic stem cell transplantation: a new etiology for acquired partial lipodystrophy.First phase insulin release and glucose tolerance in children with Fanconi anemia after hematopoietic cell transplantation.Trends in transfusion burden among long-term survivors of childhood hematological malignancies.Late complications after hematopoietic stem cell transplantation.
P2860
Q33594434-295D82DE-93B2-4164-8E5E-F1E2C050F771Q33705877-08218EEB-70B1-4A07-B43B-BFB25499A4D9Q33729496-536E41F2-1101-4F38-9B24-3CF6C46D0169Q33926274-6FB51ADE-21F4-4730-88C9-3B89ABBE69AAQ34288406-8CEB5890-5FBF-4F76-8779-22DA32DD54ADQ34419153-0196027C-50D6-4546-9673-00C65C655BC9Q34422543-29FE9CBD-A8BA-45B4-9A2B-766691DBC3BEQ34451605-F7FCC26E-9754-46BA-AD68-6C23E16E6068Q34653591-9F0B6BB2-6B4B-4780-B7D6-8821AC74ECB1Q34667855-3B3CF979-F39F-4C2D-9110-C7819E1E4FF8Q34722713-3C7A8013-2BC1-4BDF-8DA0-49B04DAA52EAQ35216345-9E0A2E08-1118-4449-9A93-B9117849849FQ35277941-883664D4-406F-45A4-826A-65F3CD4720A7Q35549037-389D60FC-F699-4548-BEA6-453FA52D8712Q35554793-AACBA2EE-CCF6-4445-95E5-C74280A9B2F1Q35628840-1AFD688A-F8FA-4B69-9050-E4F06F2B1DEAQ35738600-E2819264-8A50-4C39-9C7B-F0D469D81959Q35967618-0911855E-320B-4BBD-933D-023830BFAC36Q36004608-ECF8464E-4E06-43E2-8164-C9FCFB41A75CQ36057997-DA86E625-0249-4AD5-BC70-7C9803C8BCE4Q36369196-5D50BABF-4910-4024-9D96-34A0CFE35290Q36440055-EBD27F24-033D-4A86-B094-9483554932CEQ36486430-8F8DAFFC-82A4-49A7-B616-14FDD72667B1Q36513285-5F2280C7-95C8-4609-8C32-96026A4EECD5Q36549436-46C03FD0-320A-4582-9444-EA906284C086Q36792057-B3FEB46B-00D1-40C9-9469-2398D2E7A271Q36900984-0E477B39-C195-4F58-93CD-E98A55E633C8Q36951682-08A0314C-15DF-46FA-89DA-BCA670985A6FQ36999204-0458DB6D-C3BB-41B5-97EB-E296462244A5Q37066329-C9875B14-98C5-4942-BE80-F4DCE945E78DQ37081520-911AF323-DCFF-4FE8-B970-18ABD87DF793Q37104278-5454E332-DB56-4725-B96A-7DF5B463D70DQ37143051-7945EC07-4B3E-45B8-834E-B8D394BF175EQ37145279-C53D1AE2-CFC7-4283-A3AE-A16E4FF33E1FQ37188477-99F4FA21-1226-4532-83F2-833B39673656Q37247613-9BFC1A60-72CC-4F9E-9FCC-601BCF77D5DEQ37259059-7F31014E-061E-4BE4-A2D1-FDC104F061DBQ37331336-895F8501-3A5C-4A0D-83ED-57BDF74D8E0AQ37590225-FA93E0BF-ABB4-4B07-B439-92EBFA7D6B9BQ37810122-9C52A22E-D421-4A16-9427-57FA90A1AD3B
P2860
Impaired glucose tolerance and dyslipidaemia as late effects after bone-marrow transplantation in childhood.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Impaired glucose tolerance and ...... transplantation in childhood.
@en
Impaired glucose tolerance and ...... transplantation in childhood.
@nl
type
label
Impaired glucose tolerance and ...... transplantation in childhood.
@en
Impaired glucose tolerance and ...... transplantation in childhood.
@nl
prefLabel
Impaired glucose tolerance and ...... transplantation in childhood.
@en
Impaired glucose tolerance and ...... transplantation in childhood.
@nl
P2093
P1433
P1476
Impaired glucose tolerance and ...... transplantation in childhood.
@en
P2093
M Lipsanen-Nyman
M Taskinen
U M Saarinen-Pihkala
P304
P356
10.1016/S0140-6736(00)02717-3
P407
P577
2000-09-01T00:00:00Z